|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2003-11-26
|
|
pubmed:abstractText |
Hypertriglyceridaemia and insulin resistance are common in HIV-infected patients treated with protease inhibitors, particularly in those with lipodystrophy. Whether a therapeutic approach addressed to those metabolic abnormalities may have any impact on body fat is not clear.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1359-6535
|
|
pubmed:author |
pubmed-author:ArnaizJuan AJA,
pubmed-author:ArroyoJuan AJA,
pubmed-author:BianchiLuisL,
pubmed-author:BurgosRosaR,
pubmed-author:CasamitjanaRoserR,
pubmed-author:CongetIgnacioI,
pubmed-author:DomingoPereP,
pubmed-author:GatellJosé MJM,
pubmed-author:MartínezEstebanE,
pubmed-author:MilinkovicAnaA,
pubmed-author:MontserratEnricE,
pubmed-author:Pérez-CuevasJosé BJB,
pubmed-author:RiberaEstebanE,
pubmed-author:RocaMerceM,
pubmed-author:de LazzariElisaE
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
8
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
403-10
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:14640387-Adult,
pubmed-meshheading:14640387-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:14640387-Body Constitution,
pubmed-meshheading:14640387-Double-Blind Method,
pubmed-meshheading:14640387-Female,
pubmed-meshheading:14640387-Gemfibrozil,
pubmed-meshheading:14640387-HIV Infections,
pubmed-meshheading:14640387-HIV Protease Inhibitors,
pubmed-meshheading:14640387-HIV-Associated Lipodystrophy Syndrome,
pubmed-meshheading:14640387-Humans,
pubmed-meshheading:14640387-Hypoglycemic Agents,
pubmed-meshheading:14640387-Hypolipidemic Agents,
pubmed-meshheading:14640387-Male,
pubmed-meshheading:14640387-Metformin,
pubmed-meshheading:14640387-Prospective Studies,
pubmed-meshheading:14640387-Treatment Outcome
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Effects of metformin or gemfibrozil on the lipodystrophy of HIV-infected patients receiving protease inhibitors.
|
|
pubmed:affiliation |
Hospital Clinic-IDIBAPS, Barcelona, Spain. esteban@fundsoriano.es
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
